Journal of Asthma and Allergy
Volume 17, 2024 - Issue
SHORT REPORT
Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma
Mark Gurnell1 Department of Medicine, Wellcome–MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK;2 NIHR Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, UKCorrespondence[email protected]
https://orcid.org/0000-0001-5745-6832View further author information
https://orcid.org/0000-0001-5745-6832View further author information, Amr Radwan3 Global Medical Affairs, Regeneron Pharmaceuticals Inc., Uxbridge, UKhttps://orcid.org/0000-0003-1658-5229View further author information
https://orcid.org/0000-0003-1658-5229View further author information, , , Seong H Cho8 Division of Allergy-Immunology, Morsani College of Medicine, University of South Florida, Tampa, FL, USAhttps://orcid.org/0000-0003-0933-953XView further author information
https://orcid.org/0000-0003-0933-953XView further author information, Scott Nash9 Medical Affairs, Regeneron Pharmaceuticals Inc., Tarrytown, NY, USAhttps://orcid.org/0000-0001-9208-5280View further author information
https://orcid.org/0000-0001-9208-5280View further author information, , Asif H Khan10 Global Medical Affairs, Sanofi, Chilly-Mazarin, Francehttps://orcid.org/0000-0001-9158-0116View further author information
https://orcid.org/0000-0001-9158-0116View further author information, Juby A Jacob-Nara11 Global Medical Affairs, Sanofi, Bridgewater, NJ, USAhttps://orcid.org/0000-0002-5372-8762View further author information
https://orcid.org/0000-0002-5372-8762View further author information, & show all